Immunohistology of the Female Genital Tract

Diagnostic Immunohistochemistry, Second Edition

Volumn , Issue , 2006, Pages 637-698

  Soslow, Robert A ^a   Isacson, Christina ^b   Zaloudek, Charles ^c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b VIRGINIA MASON MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84902397560     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-443-06652-8.50022-3     Document Type: Chapter

References (440)

1. R Moll, R Levy, B Czernobilsky, et al. (1983) Cytokeratins of normal epithelia and some neoplasms of the female genital tract. Lab Invest 49 599-610.
2. JJ Puts, O Moesker, J Aldeweireldt, et al. (1987) Application of antibodies to intermediate filament proteins in simple and complex tumors of the female genital tract. Int J Gynecol Pathol 6 257-274.
3. LG Bobrow, CA Makin, S Law, et al. (1986) Expression of low molecular weight cytokeratin proteins in cervical neoplasia. J Pathol 148 135-140.
4. GC Raju (1988) Expression of the cytokeratin marker CAM5.2 in cervical neoplasia. Histopathology 12 437-443.
5. J Esquius, M Brisigotti, X Matias-Guiu, et al. (1991) Keratin expression in normal vulva, non-neoplastic epithelial disorders, vulvar intraepithelial neoplasia, and invasive squamous cell carcinoma. Int J Gynecol Pathol 10 341-355.
6. F Smedts, F Ramaekers, RE Leube, et al. (1993) Expression of keratins 1, 6, 15, 16, and 20 in normal cervical epithelium, squamous metaplasia, cervical intraepithelial neoplasia, and cervical carcinoma. Am J Pathol 142 403-412.
7. MJ Malecha and M Miettinen (1992) Patterns of keratin subsets in normal and abnormal uterine cervical tissues. An immunohistochemical study. Int J Gynecol Pathol 11 24-29.
8. A Gernow, B Nielsen, B Holund, et al. (1990) Immunohistochemical study of possible changes in keratin expression during neoplastic transformation of the uterine mucosa. Virchows Arch A Pathol Anat Histopathol 416 287-293.
9. G Cattoretti, MH Becker, G Key, et al. (1992) Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168 357-363.
10. R Bravo and H Donald-Bravo (1985) Changes in the nuclear distribution of cyclin (PCNA) but not its synthesis depend on DNA replication. EMBO J 4 655-661.
11. C Isacson, TD Kessis, L Hedrick, et al. (1996) Both cell proliferation and apoptosis increase with lesion grade in cervical neoplasia but do not correlate with human papillomavirus type. Cancer Res 56 669-674.
12. KH van Hoeven and AJ Kovatich (1996) Immunohistochemical staining for proliferating cell nuclear antigen, BCL2, and Ki-67 in vulvar tissues. Int J Gynecol Pathol 15 10-16.
13. L Geng, DC Connolly, C Isacson, et al. (1999) Atypical immature metaplasia (AIM) of the cervix: Is it related to high-grade squamous intraepithelial lesion (HSIL)? Hum Pathol 30 345-351.
14. M Resnick, S Lester, JE Tate, et al. (1996) Viral and histopathologic correlates of MN and MIB-1 expression in cervical intraepithelial neoplasia. Hum Pathol 27 234-239.
15. TA Ince, AP Cviko, BJ Quade, et al. (2002) p63 coordinates ano-genital modeling and epithelial cell differentiation in the developing female urogenital tract. Am J Pathol 161 1111-1117.
16. BJ Quade, A Yang, Y Wang, et al. (2001) Expression of the p53 homologue p63 in early cervical neoplasia. Gynecol Oncol 80 24-29.
17. TY Wang, BF Chen, YC Yang, et al. (2001) Histologic and immunophenotypic classification of cervical carcinomas by expression of the p53 homologue p63: A study of 250 cases. Hum Pathol 32 479-486.
18. BY Wang, J Gil, D Kaufman, et al. (2002) p63 in pulmonary epithelium, pulmonary squamous neoplasms, and other pulmonary tumors. Hum Pathol 33 921-926.
19. M Wu, B Wang, J Gil, et al. (2003) p63 and TTF-1 immunostaining. A useful marker panel for distinguishing small cell carcinoma of lung from poorly differentiated squamous cell carcinoma of lung. Am J Clin Pathol 119 696-702.
20. AJ Amortegui, MP Meyer, VL Elborne, et al. (1995) p53, retinoblastoma gene product, and cyclin protein expression in human papillomavirus virus DNA-positive cervical intraepithelial neoplasia and invasive cancer. Mod Pathol 8 907-912.
21. Y Xiong, D Kuppuswamy, Y Li, et al. (1996) Alteration of cell cycle kinase complexes in human papillomavirus E6- and E7-expressing fibroblasts precedes neoplastic transformation. J Virol 70 999-1008.
22. JT Keating, A Cviko, S Riethdorf, et al. (2001) Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol 25 884-891.
23. M Ishikawa, T Fujii, N Masumoto, et al. (2003) Correlation of p16INK4A overexpression with human papillomavirus infection in cervical adenocarcinomas. Int J Gynecol Pathol 22 378-385.
24. SN Agoff, P Lin, J Morihara, et al. (2003) p16(INK4a) expression correlates with degree of cervical neoplasia: a comparison with Ki-67 expression and detection of high-risk HPV types. Mod Pathol 16 665-673.
25. G Negri, E Egarter-Vigl, A Kasal, et al. (2003) p16INK4a is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors: an immunohistochemical study with immunocytochemical correlations. Am J Surg Pathol 27 187-193.
26. R Klaes, A Benner, T Friedrich, et al. (2002) p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 26 1389-1399.
27. L Riethdorf, S Riethdorf, KR Lee, et al. (2002) Human papillomaviruses, expression of p16INK4A, and early endocervical glandular neoplasia. Hum Pathol 33 899-904.
28. B Tringler, CJ Gup, M Singh, et al. (2004) Evaluation of p16INK4a and pRb expression in cervical squamous and glandular neoplasia. Hum Pathol 35 689-696.
29. MA Ansari-Lari, A Staebler, RJ Zaino, et al. (2004) Distinction of endocervical and endometrial adenocarcinomas: immunohistochemical p16 expression correlated with human papillomavirus (HPV) DNA detection. Am J Surg Pathol 28 160-167.
30. WG McCluggage and D Jenkins (2003) p16 immunoreactivity may assist in the distinction between endometrial and endocervical adenocarcinoma. Int J Gynecol Pathol 22 231-235.
31. J Albores-Saavedra, D Gersell, CB Gilks, et al. (1997) Terminology of endocrine tumors of the uterine cervix: results of a workshop sponsored by the College of American Pathologists and the National Cancer Institute. Arch Pathol Lab Med 121 34-39.
32. CB Gilks, RH Young, P Aguirre, et al. (1989) Adenoma malignum (minimal deviation adenocarcinoma) of the uterine cervix: a clinicopathological and immunohistochemical analysis of 26 cases. Am J Surg Pathol 13 717-730.
33. PR Savargaonkar, RJ Hale, A Mutton, et al. (1996) Neuroendocrine differentiation in cervical carcinoma. J Clin Pathol 49 139-141.
34. P Aguirre, RE Scully, HJ Wolfe, et al. (1984) Endometrial carcinoma with argyrophil cells: a histochemical and immunohistochemical analysis. Hum Pathol 15 210-217.
35. PG Chu, DA Arber and LM Weiss (2003) Expression of T/NK-cell and plasma cell antigens in nonhematopoietic epithelioid neoplasms. An immunohistochemical study of 447 cases. Am J Clin Pathol 120 64-70.
36. AN Viswanathan, MT Deavers, A Jhingran, et al. (2004) Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence. Gynecol Oncol 93 27-33.
37. OE Battles, DL Page and JE Johnson (1997) Cytokeratins, CEA, and mucin histochemistry in the diagnosis and characterization of extramammary Paget's disease. Am J Clin Pathol 108 6-12.
38. KJ Smith, S Tuur, D Corvette, et al. (1997) Cytokeratin 7 staining in mammary and extramammary Paget's disease. Mod Pathol 10 1069-1074.
39. K Lundquist, S Kohler and RV Rouse (1999) Intraepidermal cytokeratin 7 expression is not restricted to Paget cells but is also seen in Toker cells and Merkel cells. Am J Surg Pathol 23 212-219.
40. RR Raju, JR Goldblum and WR Hart (2003) Pagetoid squamous cell carcinoma in situ (pagetoid Bowen's disease) of the external genitalia. Int J Gynecol Pathol 22 127-135.
41. JR Goldblum and WR Hart (1997) Vulvar Paget's disease: A clinicopathologic and immunohistochemical study of 19 cases. Am J Surg Pathol 21 1178-1187.
42. JR Goldblum and WR Hart (1998) Perianal Paget's disease – A histologic and immunohistochemical study of 11 cases with and without associated rectal adenocarcinoma. Am J Surg Pathol 22 170-179.
43. S Kohler, RV Rouse and BR Smoller (1998) The differential diagnosis of pagetoid cells in the epidermis. Mod Pathol 11 79-92.
44. AS Kadish, RD Burk, Y Kress, et al. (1986) Human papillomaviruses of different types in precancerous lesions of the uterine cervix: histologic, immunocytochemical and ultrastructural studies. Hum Pathol 17 384-392.
45. J Scurry, V Beshay, C Cohen, et al. (1998) Ki-67 expression in lichen sclerosus of vulva in patients with and without associated squamous cell carcinoma. Histopathology 32 399-404.
46. EC Pirog, YT Chen and C Isacson (2000) MIB-1 immunostaining is a beneficial adjunct test for accurate diagnosis of vulvar condyloma acuminatum. Am J Surg Pathol 24 1393-1399.
47. HK Haefner, JE Tate, CM McLachlin, et al. (1995) Vulvar intraepithelial neoplasia: Age, morphological phenotype, papillomavirus DNA, and coexisting invasive carcinoma. Hum Pathol 26 147-154.
48. B Yang and WR Hart (2000) Vulvar intraepithelial neoplasia of the simplex (differentiated) type – A clinicopathologic study including analysis of HPV and p53 expression. Am J Surg Pathol 24 429-441.
49. MR Abell (1965) Intraepithelial carcinomas of epidermis and squamous mucosa of vulva and perineum. Surg Clin North Am 45 1179-1198.
50. JR Gosling, MR Abell, BM Drolette, et al. (1961) Infiltrative squamous cell (epidermoid) carcinoma of vulva. Cancer 14 330-343.
51. M Santos, C Montagut, B Mellado, et al. (2004) Immunohistochemical staining for p16 and p53 in premalignant and malignant epithelial lesions of the vulva. Int J Gynecol Pathol 23 206-214.
52. W Al-Saleh, P Delvenne, R Greimers, et al. (1995) Assessment of Ki-67 antigen immunostaining in squamous intraepithelial lesions of the uterine cervix: Correlation with the histologic grade and human papillomavirus type. Am J Clin Pathol 104 154-160.
53. WG McCluggage, M Buhidma, L Tang, et al. (1996) Monoclonal antibody MIB1 in the assessment of cervical squamous intraepithelial lesions. Int J Gynecol Pathol 15 131-136.
54. K Mittal and J Palazzo (1998) Cervical condylomas show higher proliferation than do inflamed or metaplastic cervical squamous epithelium. Mod Pathol 11 780-783.
55. K Mittal, A Mesia and RI Demopoulos (1999) MIB-1 expression is useful in distinguishing dysplasia from atrophy in elderly women. Int J Gynecol Pathol 18 122-124.
56. WG McCluggage, P Maxwell, HA McBride, et al. (1995) Monoclonal antibodies Ki-67 and MIB1 in the distinction of tuboendometrial metaplasia from endocervical adenocarcinoma and adenocarcinoma in situ in formalin-fixed material. Int J Gynecol Pathol 14 209-216.
57. KH van Hoeven, L Ramondetta, AJ Kovatich, et al. (1997) Quantitative image analysis of MIB-1 reactivity in inflammatory, hyperplastic, and neoplastic endocervical lesions. Int J Gynecol Pathol 16 15-21.
58. EC Pirog, B Kleter, S Olgac, et al. (2000) Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma. Am J Pathol 157 1055-1062.
59. Y Mikami, T Kiyokawa, S Hata, et al. (2004) Gastrointestinal immunophenotype in adenocarcinomas of the uterine cervix and related glandular lesions: a possible link between lobular endocervical glandular hyperplasia/pyloric gland metaplasia and ‘adenoma malignum’. Mod Pathol 17 962-972.
60. EC Pirog, RN Baergen, RA Soslow, et al. (2002) Diagnostic accuracy of cervical low-grade squamous intraepithelial lesions is improved with MIB-1 immunostaining. Am J Surg Pathol 26 70-75.
61. KH van Hoeven, AJ Kovatich, RE Oliver, et al. (1996) Protocol for immunocytochemical detection of SIL in cervical smears using MIB-1 antibody to Ki-67 [corrected]. Mod Pathol 9 407-412.
62. DJ Dabbs, CS Abendroth, RT Grenko, et al. (1997) Immunocytochemistry on the Thinprep processor. Diagn Cytopathol 17 388-392.
63. A Saqi, TL Pasha, CM McGrath, et al. (2002) Overexpression of p16INK4A in liquid-based specimens (SurePath) as marker of cervical dysplasia and neoplasia. Diagn Cytopathol 27 365-370.
64. S Nieh, SF Chen, TY Chu, et al. (2003) Expression of p16 INK4A in Papanicolaou smears containing atypical squamous cells of undetermined significance from the uterine cervix. Gynecol Oncol 91 201-208.
65. T Yoshida, T Fukuda, T Sano, et al. (2004) Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials. Cancer 102 100-108.
66. S Nieh, SF Chen, TY Chu, et al. (2004) Expression of p16INK4A in Pap smears containing atypical glandular cells from the uterine cervix. Acta Cytol 48 173-180.
67. WC Speers, LG Picaso and SG Silverberg (1983) Immunohistochemical localization of carcinoembryonic antigen in microglandular hyperplasia and adenocarcinoma of the endocervix. Am J Clin Pathol 79 105-107.
68. H Michael, L Grawe and FT Kraus (1984) Minimal deviation endocervical adenocarcinoma: clinical and histologic features, immunohistochemical staining for carcinoembryonic antigen, and differentiation from confusing benign lesions. Int J Gynecol Pathol 3 261-276.
69. SJ Cina, MS Richardson, RM Austin, et al. (1997) Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen, and p53 in the differential diagnosis of glandular lesions of the cervix. Mod Pathol 10 176-180.
70. DJ Dabbs, KR Geisinger and HT Norris (1986) Intermediate filaments in endometrial and endocervical carcinomas. The diagnostic utility of vimentin patterns. Am J Surg Pathol 10 568-576.
71. R Kudo, H Sasano, M Koizumi, et al. (1990) Immunohistochemical comparison of new monoclonal antibody 1C5 and carcinoembryonic antigen in the differential diagnosis of adenocarcinoma of the uterine cervix. Int J Gynecol Pathol 9 325-336.
72. G Maes, GJ Fleuren, J Bara, et al. (1988) The distribution of mucins, carcinoembryonic antigen, and mucus-associated antigens in endocervical and endometrial adenocarcinomas. Int J Gynecol Pathol 7 112-122.
73. DJ Dabbs, K Sturtz and RJ Zaino (1996) The immunohistochemical discrimination of endometrioid adenocarcinomas. Hum Pathol 27 172-177.
74. DJ Dabbs, KR Gesinger and HT Norris (1986) Intermediate filaments in endometrial and endocervical adenocarcinomas. The diagnostic utility of vimentin patterns. Am J Surg Pathol 10 568-576.
75. A Staebler, ME Sherman, RJ Zaino, et al. (2002) Hormone receptor immunohistochemistry and human papillomavirus in situ hybridization are useful for distinguishing endocervical and endometrial adenocarcinomas. Am J Surg Pathol 26 998-1006.
76. W Qiu and K Mittal (2003) Comparison of morphologic and immunohistochemical features of cervical microglandular hyperplasia with low-grade mucinous adenocarcinoma of the endometrium. Int J Gynecol Pathol 22 261-265.
77. C Zaloudek, GM Hayashi, IP Ryan, et al. (1997) Microglandular adenocarcinoma of the endometrium: a form of mucinous adenocarcinoma that may be confused with microglandular hyperplasia of the cervix. Int J Gynecol Pathol 16 52-59.
78. R Vang, R Barner, DT Wheeler, et al. (2004) Immunohistochemical staining for Ki-67 and p53 helps distinguish endometrial Arias-Stella reaction from high-grade carcinoma, including clear cell carcinoma. Int J Gynecol Pathol 23 223-233.
79. CB Gilks, RH Young, DJ Gersell, et al. (1997) Large cell neuroendocrine carcinoma of the uterine cervix: a clinicopathologic study of 12 cases. Am J Surg Pathol 21 905-914.
80. RA Ambros, JS Park, KV Shah, et al. (1991) Evaluation of histologic, morphometric, and immunohistochemical criteria in the differential diagnosis of small cell carcinomas of the cervix with particular reference to human papillomavirus types 16 and 18. Mod Pathol 4 586-593.
81. N Masumoto, T Fujii, M Ishikawa, et al. (2003) P16 overexpression and human papillomavirus infection in small cell carcinoma of the uterine cervix. Hum Pathol 34 778-783.
82. AI Farhood and J Abrams (1991) Immunohistochemistry of endometrial stromal sarcoma. Hum Pathol 22 224-230.
83. DW Franquemont, HF Frierson Jr and SE Mills (1991) An immunohistochemical study of normal endometrial stroma and endometrial stromal neoplasms. Evidence for smooth muscle differentiation. Am J Surg Pathol 15 861-870.
84. E Oliva, RH Young, PB Clement, et al. (1995) Cellular benign mesenchymal tumors of the uterus: A comparative morphologic and immunohistochemical analysis of 33 highly cellular leiomyomas and six endometrial stromal nodules, two frequently confused tumors. Am J Surg Pathol 19 757-768.
85. ME Sherman, ME Bur and RJ Kurman (1995) p53 in endometrial cancer and its putative precursors: Evidence for diverse pathways of tumorigenesis. Hum Pathol 26 1268-1274.
86. H Tashiro, C Isacson, R Levine, et al. (1997) p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis. Am J Pathol 150 177-185.
87. W Zheng, R Khurana, S Farahmand, et al. (1998) p53 immunostaining as a significant adjunct diagnostic method for uterine surface carcinoma: precursor of uterine papillary serous carcinoma. Am J Surg Pathol 22 1463-1473.
88. SF Lax, ES Pizer, BM Ronnett, et al. (1998) Comparison of estrogen and progesterone receptor, Ki-67, and p53 immunoreactivity in uterine endometrioid carcinoma and endometrioid carcinoma with squamous, mucinous, secretory, and ciliated cell differentiation. Hum Pathol 29 924-931.
89. SF Lax, B Kendall, H Tashiro, et al. (2000) The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma – Evidence of distinct molecular genetic pathways. Cancer 88 814-824.
90. MF Kohler, H Nishii, PA Humphrey, et al. (1993) Mutation of the p53 tumor-suppressor gene is not a feature of endometrial hyperplasias. Am J Obstet Gynecol 169 690-694.
91. CC Yu, N Wilkinson, MJ Brito, et al. (1993) Patterns of immunohistochemical staining for proliferating cell nuclear antigen and p53 in benign and neoplastic human endometrium. Histopathology 23 367-371.
92. RA Soslow, PU Shen, MH Chung, et al. (1998) Distinctive p53 and mdm2 immunohistochemical expression profiles suggest different pathogenetic pathways in poorly differentiated endometrial carcinoma. Int J Gynecol Pathol 17 129-134.
93. SF Lax, ES Pizer, BM Ronnett, et al. (1998) Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression. Hum Pathol 29 551-558.
94. RA Soslow, PU Shen, MH Chung, et al. (2000) Cyclin D1 expression in high-grade endometrial carcinomas – association with histologic subtype. Int J Gynecol Pathol 19 329-334.
95. JT Chambers, ML Carcangiu, IM Voynick, et al. (1990) Immunohistochemical evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma. Part II: Correlation between biochemical and immunohistochemical methods and survival. Am J Clin Pathol 94 255-260.
96. ML Carcangiu, JT Chambers, IM Voynick, et al. (1990) Immunohistochemical evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma. Part I: Clinical and histologic correlations. Am J Clin Pathol 94 247-254.
97. H Nei, T Saito, H Yamasaki, et al. (1999) Nuclear localization of beta-catenin in normal and carcinogenic endometrium. Mol Carcinog 25 207-218.
98. PW Schlosshauer, LH Ellenson and RA Soslow (2002) Beta-catenin and E-cadherin expression patterns in high-grade endometrial carcinoma are associated with histological subtype. Mod Pathol 15 1032-1037.
99. K Obata, SJ Morland, RH Watson, et al. (1998) Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors. Cancer Res 58 2095-2097.
100. JI Risinger, AK Hayes, A Berchuck, et al. (1997) PTEN/MMAC1 mutations in endometrial cancers. Cancer Res 57 4736-4738.
101. SB Simpkins, S Peiffer-Schneider, DG Mutch, et al. (1998) PTEN mutations in endometrial cancers with 10q LOH: additional evidence for the involvement of multiple tumor suppressors. Gynecol Oncol 71 391-395.
102. H Tashiro, MS Blazes, R Wu, et al. (1997) Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res 57 3935-3940.
103. Y Yokoyama, X Wan, A Shinohara, et al. (2000) Expression of PTEN and PTEN pseudogene in endometrial carcinoma. Int J Mol Med 6 47-50.
104. F Darvishian, AJ Hummer, HT Thaler, et al. (2004) Serous endometrial cancers that mimic endometrioid adenocarcinomas: a clinicopathologic and immunohistochemical study of a group of problematic cases. Am J Surg Pathol 28 1568-1578.
105. T Fukuchi, M Sakamoto, H Tsuda, et al. (1998) Beta-catenin mutation in carcinoma of the uterine endometrium. Cancer Res 58 3526-3528.
106. M Saegusa, M Hamano, T Kuwata, et al. (2003) Up-regulation and nuclear localization of beta-catenin in endometrial carcinoma in response to progesterone therapy. Cancer Sci 94 103-111.
107. E Oliva, PB Clement, RH Young, et al. (1998) Mixed endometrial stromal and smooth muscle tumors of the uterus – A clinicopathologic study of 15 cases. Am J Surg Pathol 22 997-1005.
108. E Oliva, RH Young, PB Clement, et al. (1999) Myxoid and fibrous endometrial stromal tumors of the uterus: a report of 10 cases. Int J Gynecol Pathol 18 310-319.
109. RJ Baker, RH Hildebrandt, RV Rouse, et al. (1999) Inhibin and CD99 (MIC2) expression in uterine stromal neoplasms with sex-cord-like elements. Hum Pathol 30 671-679.
110. MN Rizeq, M Van de Rijn, MR Hendrickson, et al. (1994) A comparative immunohistochemical study of uterine smooth muscle neoplasms with emphasis on the epithelioid variant. Hum Pathol 25 671-677.
111. JM Meis and WD Lawrence (1990) The immunohistochemical profile of malignant mixed mullerian tumor. Overlap with endometrial adenocarcinoma. Am J Clin Pathol 94 1-7.
112. MR Nucci, JT O'Connell, PC Huettner, et al. (2001) h-Caldesmon expression effectively distinguishes endometrial stromal tumors from uterine smooth muscle tumors. Am J Surg Pathol 25 455-463.
113. DS Rush, JY Tan, RN Baergen, et al. (2001) h-caldesmon, a novel smooth muscle-specific antibody, distinguishes between cellular leiomyoma and endometrial stromal sarcoma. Am J Surg Pathol 25 253-258.
114. C Loddenkemper, S Mechsner, HD Foss, et al. (2003) Use of oxytocin receptor expression in distinguishing between uterine smooth muscle tumors and endometrial stromal sarcoma. Am J Surg Pathol 27 1458-1462.
115. PG Chu, DA Arber, LM Weiss, et al. (2001) Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases. Mod Pathol 14 465-471.
116. E Oliva, RH Young, MB Amin, et al. (2002) An immunohistochemical analysis of endometrial stromal and smooth muscle tumors of the uterus – A study of 54 cases emphasizing the importance of using a panel because of overlap in immunoreactivity for individual antibodies. Am J Surg Pathol 26 403-412.
117. WG McCluggage, VP Sumathi and P Maxwell (2001) CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms. Histopathology 39 273-278.
118. SN Agoff, VS Grieco, R Garcia, et al. (2001) Immunohistochemical distinction of endometrial stromal sarcoma and cellular leiomyoma. Appl Immunohistochem Mol Morphol 9 164-169.
119. VP Sumathi, M Al-Hussaini, LE Connolly, et al. (2004) Endometrial stromal neoplasms are immunoreactive with WT-1 antibody. Int J Gynecol Pathol 23 241-247.
120. M Srodon, WM Klein and RJ Kurman (2003) CD10 immunostaining does not distinguish endometrial carcinoma invading myometrium from carcinoma involving adenomyosis. Am J Surg Pathol 27 786-789.
121. AF Nascimento, MS Hirsch, A Cviko, et al. (2003) The role of CD10 staining in distinguishing invasive endometrial adenocarcinoma from adenocarcinoma involving adenomyosis. Mod Pathol 16 22-27.
122. ML Carcangiu and JT Chambers (1992) Uterine papillary serous carcinoma: a study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma. Gynecol Oncol 47 298-305.
123. ME Sherman, P Bitterman, NB Rosenshein, et al. (1992) Uterine serous carcinoma: A morphologically diverse neoplasm with unifying clinicopathologic features. Am J Surg Pathol 16 600-610.
124. A Yilmaz, DS Rush and RA Soslow (2002) Endometrial stromal sarcomas with unusual histologic features: a report of 24 primary and metastatic tumors emphasizing fibroblastic and smooth muscle differentiation. Am J Surg Pathol 26 1142-1150.
125. PB Clement and RE Scully (1976) Uterine tumors resembling ovarian sex-cord tumors. A clinicopathologic analysis of 14 cases. Am J Clin Pathol 66 512-525.
126. PB Clement and RE Scully (1992) Endometrial stromal sarcomas of the uterus with extensive glandular differentiation: a report of three cases that caused problems in differential diagnosis. Int J Gynecol Pathol 11 163-173.
127. R Bhargava, J Shia, AJ Hummer, et al. (2005) Distinction of endometrial stromal sarcomas from ‘hemangiopericytomatous’ tumors using a panel of immunohistochemical stains. Mod Pathol 18 40-47.
128. YL Zhai, Y Kobayashi, A Mori, et al. (1999) Expression of steroid receptors, Ki-67, and p53 in uterine leiomyosarcomas. Int J Gynecol Pathol 18 20-28.
129. RR Nordal, GB Kristensen, AE Stenwig, et al. (1998) Immunohistochemical analysis of p53 protein in uterine sarcomas. Gynecol Oncol 70 45-48.
130. R Blom, C Guerrieri, O Stal, et al. (1998) Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases. Gynecol Oncol 68 54-61.
131. MM Leitao, RA Soslow, D Nonaka, et al. (2004) Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma. Cancer 101 1455-1462.
132. R Vang and RL Kempson (2002) Perivascular epithelioid cell tumor (‘PEComa’) of the uterus: a subset of HMB-45-positive epithelioid mesenchymal neoplasms with an uncertain relationship to pure smooth muscle tumors. Am J Surg Pathol 26 1-13.
133. EG Silva, MT Deavers, DC Bodurka, et al. (2004) Uterine epithelioid leiomyosarcomas with clear cells: reactivity with HMB-45 and the concept of PEComa. Am J Surg Pathol 28 244-249.
134. WM Klein and RJ Kurman (2003) Lack of expression of c-kit protein (CD117) in mesenchymal tumors of the uterus and ovary. Int J Gynecol Pathol 22 181-184.
135. WE Winter III, JD Seidman, TC Krivak, et al. (2003) Clinicopathological analysis of c-kit expression in carcinosarcomas and leiomyosarcomas of the uterine corpus. Gynecol Oncol 91 3-8.
136. L Wang, JC Felix, JL Lee, et al. (2003) The proto-oncogene c-kit is expressed in leiomyosarcomas of the uterus. Gynecol Oncol 90 402-406.
137. RS Rushing, S Shajahan, D Chendil, et al. (2003) Uterine sarcomas express KIT protein but lack mutation(s) in exon 11 or 17 of c-KIT. Gynecol Oncol 91 9-14.
138. K Ito, K Watanabe, S Nasim, et al. (1994) Prognostic significance of p53 overexpression in endometrial cancer. Cancer Res 54 4667-4670.
139. CJ Sung, Y Zheng, MR Quddus, et al. (2000) p53 as a significant prognostic marker in endometrial carcinoma. Int J Gynecol Cancer 10 119-127.
140. A Alkushi, P Lim, A Coldman, et al. (2004) Interpretation of p53 immunoreactivity in endometrial carcinoma: establishing a clinically relevant cutoff level. Int J Gynecol Pathol 23 129-137.
141. J Dupont, X Wang, DS Marshall, et al. (2004) Wilms' tumor gene (WT1) and p53 expression in endometrial carcinomas: a study of 130 cases using a tissue microarray. Gynecol Oncol 94 449-455.
142. D Daya and L Sabet (1991) The use of cytokeratin as a sensitive and reliable marker for trophoblastic tissue. Am J Clin Pathol 95 137-141.
143. RJ Kurman, RH Young, HJ Norris, et al. (1984) Immunocytochemical localization of placental lactogen and chorionic gonadotropin in the normal placenta and trophoblastic tumors, with emphasis on intermediate trophoblast and the placental site trophoblastic tumor. Int J Gynecol Pathol 3 101-121.
144. PC Huettner and DJ Gersell (1994) Placental site nodule: a clinicopathologic study of 38 cases. Int J Gynecol Pathol 13 191-198.
145. IT Yeh, DM O'Connor and RJ Kurman (1989) Vacuolated cytotrophoblast: a subpopulation of trophoblast in the chorion laeve. Placenta 10 429-438.
146. IM Shih and RJ Kurman (1996) Expression of melanoma cell adhesion molecule in intermediate trophoblast. Lab Invest 75 377-388.
147. IM Shih and RJ Kurman (2004) p63 expression is useful in the distinction of epithelioid trophoblastic and placental site trophoblastic tumors by profiling trophoblastic subpopulations. Am J Surg Pathol 28 1177-1183.
148. M Fukunaga (2002) Immunohistochemical characterization of p57 (KIP2) expression in early hydatidiform moles. Hum Pathol 33 1188-1192.
149. RA Fisher, MD Hodges, HC Rees, et al. (2002) The maternally transcribed gene p57 (KIP2) (CDNK1C) is abnor-mally expressed in both androgenetic and biparental complete hydatidiform moles. Hum Mol Genet 11 3267-3272.
150. DR Genest, DM Dorfman and DH Castrillon (2002) Ploidy and imprinting in hydatidiform moles. Complementary use of flow cytometry and immunohistochemistry of the imprinted gene product p57KIP2 to assist molar classification. J Reprod Med 47 342-346.
151. DH Castrillon, DQ Sun, S Weremowicz, et al. (2001) Discrimination of complete hydatidiform mole from its mimics by immunohistochemistry of the paternally imprinted gene product p57KIP2. Am J Surg Pathol 25 1225-1230.
152. IM Shih, JD Seidman and RJ Kurman (1999) Placental site nodule and characterization of distinctive types of intermediate trophoblast. Hum Pathol 30 687-694.
153. IM Shih and RJ Kurman (1998) Ki-67 labeling index in the differential diagnosis of exaggerated placental site, placental site trophoblastic tumor, and choriocarcinoma: A double immunohistochemical staining technique using Ki-67 and Mel-CAM antibodies. Hum Pathol 29 27-33.
154. E Angel, JR Davis and RB Nagle (1985) Immunohistochemical demonstration of placental hormones in the diagnosis of uterine versus ectopic pregnancy. Am J Clin Pathol 84 705-709.
155. A Hameed, DS Miller, CY Muller, et al. (1999) Frequent expression of beta-human chorionic gonadotropin (beta-hCG) in squamous cell carcinoma of the cervix. Int J Gynecol Pathol 18 381-386.
156. CE Bacchi, KI Coelho and J Goldberg (1993) Expression of beta-human chorionic gonadotropin (beta-hCG) in non-trophoblastic elements of transitional cell carcinoma of the bladder: possible relationship with the prognosis. Rev Paul Med 111 412-416.
157. FA Tavassoli (2003) Pathology and genetics of tumours of the breast and female genital organs Lyon: IARC Press
158. R Moll, WW Franke, DL Schiller, et al. (1982) The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31 11-24.
159. K Berezowski, JF Stastny and MJ Kornstein (1996) Cytokeratins 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma. Mod Pathol 9 426-429.
160. JH Lagendijk, H Mullink, PJ Van Diest, et al. (1999) Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach. J Clin Pathol 52 283-290.
161. HP Cathro and MH Stoler (2002) Expression of cytokeratins 7 and 20 in ovarian neoplasia. Am J Clin Pathol 117 944-951.
162. NP Wang, S Zee, RJ Zarbo, et al. (1995) Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas. Appl Immunohistochem 3 99-107.
163. P Chu, E Wu and LM Weiss (2000) Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol 13 962-972.
164. MR Raspollini, G Amunni, A Villanucci, et al. (2004) Utility of CDX-2 in distinguishing between primary and secondary (intestinal) mucinous ovarian carcinoma: an immunohistochemical comparison of 43 cases. Appl Immunohistochem Mol Morphol 12 127-131.
165. R Moll, A Lowe, J Laufer, et al. (1992) Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol 140 427-447.
166. M Miettinen (1995) Keratin 20: immunohistochemical marker for gastrointestinal, urothelial, and Merkel cell carcinomas. Mod Pathol 8 384-388.
167. CCAP Wauters, F Smedts, LGM Gerrits, et al. (1995) Keratins 7 and 20 as diagnostic markers of carcinomas metastatic to the ovary. Hum Pathol 26 852-855.
168. TS Loy, RD Calaluce and GL Keeney (1996) Cytokeratin immunostaining in differentiating primary ovarian carcinoma from metastatic colonic adenocarcinoma. Mod Pathol 9 1040-1044.
169. H Ji, C Isacson, JD Seidman, et al. (2002) Cytokeratins 7 and 20, Dpc4, and MUC5AC in the distinction of metastatic mucinous carcinomas in the ovary from primary ovarian mucinous tumors: Dpc4 assists in identifying metastatic pancreatic carcinomas. Int J Gynecol Pathol 21 391-400.
170. NG Ordonez (1998) Role of immunohistochemistry in distinguishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serous carcinomas. Am J Surg Pathol 22 1203-1214.
171. P Ramalingam, A Malpica, EG Silva, et al. (2004) The use of cytokeratin 7 and EMA in differentiating ovarian yolk sac tumors from endometrioid and clear cell carcinomas. Am J Surg Pathol 28 1499-1505.
172. RL Attanoos, R Webb, SD Dojcinov, et al. (2002) Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum. Histopathology 40 237-244.
173. C Charpin, AK Bhan, VRJ Zurawski, et al. (1982) Carcinoembryonic antigen (CEA) and carbohydrate determinant 19–9 (CA 19–9) localization in 121 primary and metastatic ovarian tumors: an immunohistochemical study with the use of monoclonal antibodies. Int J Gynecol Pathol 1 231-245.
174. RW Brown, LB Campagna, JK Dunn, et al. (1997) Immunohistochemical identification of tumor markers in metastatic adenocarcinoma. A diagnostic adjunct in the determination of primary site. Am J Clin Pathol 107 12-19.
175. JH Lagendijk, H Mullink, PJ Van Diest, et al. (1998) Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: Differential diagnosis between colonic and ovarian carcinomas as primary sites. Hum Pathol 29 491-497.
176. N Ulfig (2002) Calcium-binding proteins in the human developing brain. Adv Anat Embryol Cell Biol 165(III-IX), 1-92.
177. YY Chou, YM Jeng, HL Kao, et al. (2003) Differentiation of ovarian mucinous carcinoma and metastatic colorectal adenocarcinoma by immunostaining with beta-catenin. Histopathology 43 151-156.
178. NS Goldstein, D Bassi and A Uzieblo (2001) WT1 is an integral component of an antibody panel to distinguish pancreatico-biliary and some ovarian epithelial neoplasms. Am J Clin Pathol 116 246-252.
179. HA Multhaupt, CP Arenas-Elliott and MJ Warhol (1999) Comparison of glycoprotein expression between ovarian and colon adenocarcinomas. Arch Pathol Lab Med 123 909-916.
180. A Thor, F Gorstein, N Ohuchi, et al. (1986) Tumor-associated glycoprotein (TAG-72) in ovarian carcinomas defined by monoclonal antibody B72.3. J Natl Cancer Inst 76 995-1006.
181. DJ Bollinger, MR Wick, LP Dehner, et al. (1989) Peritoneal malignant mesothelioma versus serous papillary adenocarcinoma. A histochemical and immunohistochemical comparison. Am J Surg Pathol 13 659-670.
182. TJ O'Brien, JB Beard, LJ Underwood, et al. (2001) The CA 125 gene: An extracellular superstructure dominated by repeat sequences. Tumor Biol 22 348-366.
183. TJ O'Brien, JB Beard, LJ Underwood, et al. (2002) The CA 125 gene: A newly discovered extension of the glycosylated N-terminal domain doubles the size of this extracellular superstructure. Tumor Biol 23 154-169.
184. RC Bast Jr, FJ Xu, YH Yu, et al. (1998) CA 125: the past and the future. Int J Biol Markers 13 179-187.
185. TS Loy, JT Quesenberry and SC Sharp (1992) Distribution of CA 125 in adenocarcinomas: An immunohistochemical study of 481 cases. Am J Clin Pathol 98 175-179.
186. IA Koelma, M Nap, CJ Rodenburg, et al. (1987) The value of tumour marker CA 125 in surgical pathology. Histopathology 11 287-294.
187. CE Keen, S Szakacs, E Okon, et al. (1999) CA 125 and thyroglobulin staining in papillary carcinomas of thyroid and ovarian origin is not completely specific for site of origin. Histopathology 34 113-117.
188. M Nap, A Vitali, K Nustad, et al. (1996) Immunohistochemical characterization of 22 monoclonal antibodies against the CA 125 antigen: 2nd report from the ISOBM TD-1 workshop. Tumor Biol 17 325-331.
189. J Leake, RP Woolas, J Daniel, et al. (1994) Immunocytochemical and serological expression of CA 125: A clinicopathological study of 40 malignant ovarian epithelial tumours. Histopathology 24 57-64.
190. W Zheng, BZ Senturk and V Parkash (2003) Inhibin immunohistochemical staining: a practical approach for the surgical pathologist in the diagnoses of ovarian sex cord-stromal tumors. Adv Anat Pathol 10 27-38.
191. C Rivier, H Meunier, V Roberts, et al. (1990) Inhibin: role and secretion in the rat. Recent Prog Horm Res 46 231-257.
192. W Vale, C Rivier, A Hsueh, et al. (1988) Chemical and biological characterization of the inhibin family of protein hormones. Recent Prog Horm Res 44 1-34.
193. CK Welt (2002) The physiology and pathophysiology of inhibin, activin and follistatin in female reproduction. Curr Opin Obstet Gynecol 14 317-323.
194. M Rishi, LN Howard, GL Bratthauer, et al. (1997) Use of monoclonal antibody against human inhibin as a marker for sex cord-stromal tumors of the ovary. Am J Surg Pathol 21 583-589.
195. MJ Costa, PF Ames, J Walls, et al. (1997) Inhibin immunohistochemistry applied to ovarian neoplasms: A novel, effective, diagnostic tool. Hum Pathol 28 1247-1254.
196. RH Hildebrandt, RV Rouse and TA Longacre (1997) Value of inhibin in the identification of granulosa cell tumors of the ovary. Hum Pathol 28 1387-1395.
197. F Kommoss, E Oliva, AK Bhan, et al. (1998) Inhibin expression in ovarian tumors and tumor-like lesions: an immunohistochemical study. Mod Pathol 11 656-664.
198. WG McCluggage (2001) Value of inhibin staining in gynecological pathology. Int J Gynecol Pathol 20 79-85.
199. MT Deavers, A Malpica, J Liu, et al. (2003) Ovarian sex cord-stromal tumors: an immunohistochemical study including a comparison of calretinin and inhibin. Mod Pathol 16 584-590.
200. TJ Pelkey, HFJ Frierson, SE Mills, et al. (1998) The diagnostic utility of inhibin staining in ovarian neoplasms. Int J Gynecol Pathol 17 97-105.
201. X Matias-Guiu, C Pons and J Prat (1998) Mullerian inhibiting substance, alpha-inhibin, and CD99 expression in sex cord-stromal tumors and endometrioid ovarian carcinomas resembling sex cord-stromal tumors. Hum Pathol 29 840-845.
202. DX Yao, RA Soslow, CV Hedvat, et al. (2003) Melan-A (A103) and inhibin expression in ovarian neoplasms. Appl Immunohistochem Mol Morphol 11 244-249.
203. WG McCluggage, J Burton, P Maxwell, et al. (1998) Immunohistochemical staining of normal, hyperplastic, and neoplastic adrenal cortex with a monoclonal antibody against alpha inhibin. J Clin Pathol 51 114-116.
204. TJ Pelkey, HFJ Frierson, SE Mills, et al. (1998) The alpha subunit of inhibin in adrenal cortical neoplasia. Mod Pathol 11 516-524.
205. A Chivite, X MatiasGuiu, C Pons, et al. (1998) Inhibin A expression in adrenal neoplasms – A new immunohistochemical marker for adrenocortical tumors. Appl Immunohistochem Mol Morphol 6 42-49.
206. EY Cho and GH Ahn (2001) Immunoexpression of inhibin alpha-subunit in adrenal neoplasms. Appl Immunohistochem Mol Morphol 9 222-228.
207. M Jorda, MB De and M Nadji (2002) Calretinin and inhibin are useful in separating adrenocortical neoplasms from pheochromocytomas. Appl Immunohistochem Mol Morphol 10 67-70.
208. PJ Zhang, EM Genega, JE Tomaszewski, et al. (2003) The role of calretinin, inhibin, melan-A, BCL-2, and C-kit in differentiating adrenal cortical and medullary tumors: an immunohistochemical study. Mod Pathol 16 591-597.
209. JH Rogers (1987) Calretinin: a gene for a novel calcium-binding protein expressed principally in neurons. J Cell Biol 105 1343-1353.
210. AP Tos and C Doglioni (1998) Calretinin: a novel tool for diagnostic immunohistochemistry. Adv Anat Pathol 5 61-66.
211. J Rogers, M Khan and J Ellis (1990) Calretinin and other CaBPs in the nervous system. Adv Exp Med Biol 269 195-203.
212. QJ Cao, JG Jones and M Li (2001) Expression of calretinin in human ovary, testis, and ovarian sex cord-stromal tumors. Int J Gynecol Pathol 20 346-352.
213. WG McCluggage and P Maxwell (2001) Immunohistochemical staining for calretinin is useful in the diagnosis of ovarian sex cord-stromal tumours. Histopathology 38 403-408.
214. S Movahedi-Lankarani and RJ Kurman (2002) Calretinin, a more sensitive but less specific marker than alpha-inhibin for ovarian sex cord-stromal neoplasms – An immunohistochemical study of 215 cases. Am J Surg Pathol 26 1477-1483.
215. SB Lee and DA Haber (2001) Wilms tumor and the WT1 gene. Exp Cell Res 264 74-99.
216. TE Mrir, X Cheville and DJ Layer (2001) Metanephric adenoma, nephrogeric rests, and Wilms' tumor – A histologic and immunophenotypic comparison. Am J Surg Pathol 25 1290-1296.
217. NG Ordonez (1998) Desmoplastic small round cell tumor II: An ultrastructural and immunohistochemical study with emphasis on new immunohistochemical markers. Am J Surg Pathol 22 1314-1327.
218. DA Hill, JD Pfeifer, EF Marley, et al. (2000) WT1 staining reliably differentiates desmoplastic small round cell tumor from Ewing sarcoma/primitive neuroectodermal tumor – An immunohistochemical and molecular diagnostic study. Am J Clin Pathol 114 345-353.
219. ME Lae, PC Roche, L Jin, et al. (2002) Desmoplastic small round cell tumor – A clinicopathologic, immunohistochemical, and molecular study of 32 tumors. Am J Surg Pathol 26 823-835.
220. H Hwang, L Quenneville, H Yaziji, et al. (2004) Wilms tumor gene product: sensitive and contextually specific marker of serous carcinomas of ovarian surface epithelial origin. Appl Immunohistochem Mol Morphol 12 122-126.
221. NG Ordonez (2000) Value of thyroid transcription factor-1, E-cadherin, BG8, WT1, and CD44S immunostaining in distinguishing epithelial pleural mesothelioma from pulmonary and nonpulmonary adenocarcinoma. Am J Surg Pathol 24 598-606.
222. M Shimizu, T Toki, Y Takagi, et al. (2000) Immunohistochemical detection of the Wilms' tumor gene (WT1) in epithelial ovarian tumors. Int J Gynecol Pathol 19 158-163.
223. G Acs, T Pasha and PJ Zhang (2004) WT1 is differentially expressed in serous, endometrioid, clear cell, and mucinous carcinomas of the peritoneum, fallopian tube, ovary, and endometrium. Int J Gynecol Pathol 23 110-118.
224. S Logani, E Oliva, MB Amin, et al. (2003) Immunoprofile of ovarian tumors with putative transitional cell (urothelial) differentiation using novel urothelial markers: histogenetic and diagnostic implications. Am J Surg Pathol 27 1434-1441.
225. WG McCluggage, E Oliva, LE Connolly, et al. (2004) An immunohistochemical analysis of ovarian small cell carcinoma of hypercalcemic type. Int J Gynecol Pathol 23 330-336.
226. L Nakopoulou, K Stefanaki, J Janinis, et al. (1995) Immunohistochemical expression of placental alkaline phosphatase and vimentin in epithelial ovarian neoplasms. Acta Oncol 34 511-515.
227. EJ Nouwen, PG Hendrix, S Dauwe, et al. (1987) Tumor markers in the human ovary and its neoplasms. A comparative immunohistochemical study. Am J Pathol 126 230-242.
228. B Lifschitz-Mercer, H Walt, I Kushnir, et al. (1995) Differentiation potential of ovarian dysgerminoma: An immunohistochemical study of 15 cases. Hum Pathol 26 62-66.
229. J Hustin, Y Gillerot, J Collette, et al. (1990) Placental alkaline phosphatase in developing normal and abnormal gonads and in germ-cell tumours. Virchows Arch A Pathol Anat Histopathol 417 67-72.
230. DA Arber, R Tamayo and LM Weiss (1998) Paraffin section detection of the c-kit gene product (CD117) in human tissues: Value in the diagnosis of mast cell disorders. Hum Pathol 29 498-504.
231. PC Gibson and K Cooper (2002) CD117 (KIT): a diverse protein with selective applications in surgical pathology. Adv Anat Pathol 9 65-69.
232. M Sarlomo-Rikala, AJ Kovatich, A Barusevicius, et al. (1998) CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol 11 728-734.
233. M Miettinen, M Sarlomo-Rikala and J Lasota (1999) Gastrointestinal stromal tumors: Recent advances in understanding of their biology. Hum Pathol 30 1213-1220.
234. JR Lee, V Joshi, JW Griffin Jr, et al. (2001) Gastrointestinal autonomic nerve tumor – Immunohistochemical and molecular identity with gastrointestinal stromal tumor. Am J Surg Pathol 25 979-987.
235. X Leroy, D Augusto, E Leteurtre, et al. (2002) CD30 and CD117 (c-kit) used in combination are useful for distinguishing embryonal carcinoma from seminoma. J Histochem Cytochem 50 283-285.
236. D Harms and U Janig (1986) Germ cell tumours of childhood. Report of 170 cases including 59 pure and partial yolk-sac tumours. Virchows Arch [A] 409 223-239.
237. PB Clement, RH Young and RE Scully (1987) Endometrioid-like variant of ovarian yolk sac tumor. A clinicopathological analysis of eight cases. Am J Surg Pathol 11 767-778.
238. RJ Kurman and HJ Norris (1976) Endodermal sinus tumor of the ovary. A clinical and pathologic analysis of 71 cases. Cancer 38 2404-2419.
239. J Prat, AK Bhan, GR Dickersin, et al. (1982) Hepatoid yolk sac tumor of the ovary (endodermal sinus tumor with hepatoid differentiation): a light microscopic, ultrastructural and immunohistochemical study of seven cases. Cancer 50 2355-2368.
240. TA Zirker, EG Silva, M Morris, et al. (1989) Immunohistochemical differentiation of clear-cell carcinoma of the female genital tract and endodermal sinus tumor with the use of alpha-fetoprotein and Leu-M1. Am J Clin Pathol 91 511-514.
241. M Devouassoux-Shisheboran, DP Schammel and FA Tavassoli (1999) Ovarian hepatoid yolk sac tumours: morphological, immunohistochemical and ultrastructural features. Histopathology 34 462-469.
242. H Ishikura and RE Scully (1987) Hepatoid carcinoma of the ovary. A newly described tumor. Cancer 60 2775-2784.
243. MB Pitman, S Triratanachat, RH Young, et al. (2004) Hepatocyte paraffin 1 antibody does not distinguish primary ovarian tumors with hepatoid differentiation from metastatic hepatocellular carcinoma. Int J Gynecol Pathol 23 58-64.
244. N Tochigi, T Kishimoto, Y Supriatna, et al. (2003) Hepatoid carcinoma of the ovary: a report of three cases admixed with a common surface epithelial carcinoma. Int J Gynecol Pathol 22 266-271.
245. RH Young, DJ Gersell, PB Clement, et al. (1992) Hepatocellular carcinoma metastatic to the ovary: A report of three cases discovered during life with discussion of the differential diagnosis of hepatoid tumors of the ovary. Hum Pathol 23 574-580.
246. S Gagnon, B Tëtu, EG Silva, et al. (1989) Frequency of alpha-fetoprotein production by Sertoli-Leydig cell tumors of the ovary: an immunohistochemical study of eight cases. Mod Pathol 2 63-67.
247. A Hammad, KM Jasnosz and PR Olson (1995) Expression of alpha-fetoprotein by ovarian Sertoli-Leydig cell tumors – Case report and review of the literature. Arch Pathol Lab Med 119 1075-1079.
248. EE Mooney, FF Nogales and FA Tavassoli (1999) Hepatocytic differentiation in retiform Sertoli-Leydig cell tumors: distinguishing a heterologous element from Leydig cells. Hum Pathol 30 611-617.
249. GA Niehans, JC Manivel, GT Copland, et al. (1988) Immunohistochemistry of germ cell and trophoblastic neoplasms. Cancer 62 1113-1123.
250. T Perrone, TA Steeper and LP Dehner (1987) Alpha-fetoprotein localization in pure ovarian teratoma. An immunohistochemical study of 12 cases. Am J Clin Pathol 88 713-717.
251. RJ Kurman and HJ Norris (1976) Embryonal carcinoma of the ovary: a clinicopathologic entity distinct from endodermal sinus tumor resembling embryonal carcinoma of the adult testis. Cancer 38 2420-2433.
252. G Ueda, Y Abe, M Yoshida, et al. (1990) Embryonal carcinoma of the ovary: a six-year survival. Int J Gynaecol Obstet 31 287-292.
253. N Nakashima, T Fukatsu, T Nagasaka, et al. (1987) The frequency and histology of hepatic tissue in germ cell tumors. Am J Surg Pathol 11 682-692.
254. M Furumoto (1981) Cellular localization of AFP, hCG and its free subunits, and SP1 in embryonal carcinoma of the testis and ovary. Pathol Res Pract 173 12-21.
255. FF Nogales, C Bergeron, RE Carvia, et al. (1996) Ovarian endometrioid tumors with yolk sac tumor component; an unusual form of ovarian neoplasm – Analysis of six cases. Am J Surg Pathol 20 1056-1066.
256. JM Lopez, A Malpica, MT Deavers, et al. (2003) Ovarian yolk sac tumor associated with endometrioid carcinoma and mucinous cystadenoma of the ovary. Ann Diagn Pathol 7 300-305.
257. RJ Kurman, PT Scardino, KR McIntire, et al. (1977) Cellular localization of alpha-fetoprotein and human chorionic gonadotropin in germ cell tumors of the testis using an indirect immunoperoxidase technique. Cancer 40 2136-2151.
258. J Hustin, AM Reuter and P Franchimont (1985) Immunohistochemical localization of hCG and its subunits in testicular germ cell tumours. Virchows Arch A Pathol Anat Histopathol 406 333-338.
259. CJ Zaloudek, FA Tavassoli and HJ Norris (1981) Dysgerminoma with syncytiotrophoblastic giant cells: a histologically and clinically distinctive subtype of dysgerminoma. Am J Surg Pathol 5 361-367.
260. E Oliva, E Andrada, E Pezzica, et al. (1993) Ovarian carcinomas with choriocarcinomatous differentiation. Cancer 72 2441-2446.
261. X Matias-Guiu and J Prat (1990) Ovarian tumors with functioning stroma. An immunohistochemical study of 100 cases with human chorionic gonadotropin monoclonal and polyclonal antibodies. Cancer 65 2001-2005.
262. J Mohabeer, CH Buckley and H Fox (1983) An immunohistochemical study of the incidence and significance of human chorionic gonadotrophin synthesis by epithelial ovarian neoplasms. Gynecol Oncol 16 78-84.
263. R Donato (2001) S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 33 637-668.
264. R Donato (2003) Intracellular and extracellular roles of S100 proteins. Microsc Res Tech 60 540-551.
265. CW Heizmann, G Fritz and BW Schafer (2002) S100 proteins: structure, functions and pathology. Front Biosci 7 d1356-d1368.
266. D Gupta, MT Deavers, EG Silva, et al. (2004) Malignant melanoma involving the ovary: a clinicopathologic and immunohistochemical study of 23 cases. Am J Surg Pathol 28 771-780.
267. JK Drier, PE Swanson, DL Cherwitz, et al. (1987) S100 protein immunoreactivity in poorly differentiated carcinomas. Immunohistochemical comparison with malignant melanoma. Arch Pathol Lab Med 111 447-452.
268. GA Herrera, EA Turbat-Herrera and RL Lott (1988) S-100 protein expression by primary and metastatic adenocarcinomas. Am J Clin Pathol 89 168-176.
269. AA Jungbluth, KJ Busam, WL Gerald, et al. (1998) A103 – An anti-Melan-A monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues. Am J Surg Pathol 22 595-602.
270. CE Bacchi, F Bonetti, M Pea, et al. (1996) HMB-45: A review. Appl Immunohistochem 4 73-85.
271. AM Gown, AM Vogel, D Hoak, et al. (1986) Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes. Am J Pathol 123 195-203.
272. MR Wick, PE Swanson and A Rocamora (1988) Recognition of malignant melanoma by monoclonal antibody HMB-45. An immunohistochemical study of 200 paraffin-embedded cutaneous tumors. J Cutan Pathol 15 201-207.
273. V Hoon, SN Thung, M Kaneko, et al. (1994) HMB-45 reactivity in renal angiomyolipoma and lymphangioleiomyomatosis. Arch Pathol Lab Med 118 732-734.
274. KA Gyure, WR Hart and AW Kennedy (1995) Lymphangiomyomatosis of the uterus associated with tuberous sclerosis and malignant neoplasia of the female genital tract: a report of two cases. Int J Gynecol Pathol 14 344-351.
275. TA Longacre, MR Hendrickson, DS Kapp, et al. (1996) Lymphangioleiomyomatosis of the uterus simulating high-stage endometrial stromal sarcoma. Gynecol Oncol 63 404-410.
276. AE Anderson, X Yang and RH Young (2002) Epithelioid angiomyolipoma of the ovary: a case report and literature review. Int J Gynecol Pathol 21 69-73.
277. HR Makhlouf, KG Ishak, R Shekar, et al. (2002) Melanoma markers in angiomyolipoma of the liver and kidney – A comparative study. Arch Pathol Lab Med 126 49-55.
278. CH Stone, MW Lee, MB Amin, et al. (2001) Renal angiomyolipoma – Further immunophenotypic characterization of an expanding morphologic spectrum. Arch Pathol Lab Med 125 751-758.
279. K Matsui, A Tatsuguchi, J Valencia, et al. (2000) Extrapulmonary lymphangioleiomyomatosis (LAM): Clinicopathologic features in 22 cases. Hum Pathol 31 1242-1248.
280. KJ Busam, K Iversen, KA Coplan, et al. (1998) Immunoreactivity for A103, an antibody to Melan-A (MART-1), in adrenocortical and other steroid tumors. Am J Surg Pathol 22 57-63.
281. LM Weiss and KL Chang (1993) CD 45: a review. Appl Immunohistochem 1 166-181.
282. AGJM Hanselaar, GP Vooijs, B Mayall, et al. (1993) Epithelial markers to detect occult microinvasion in serous ovarian tumors. Int J Gynecol Pathol 12 20-27.
283. HAB Multhaupt, CP Arenas-Elliott and MJ Warhol (1999) Comparison of glycoprotein expression between ovarian and colon adenocarcinomas. Arch Pathol Lab Med 123 909-916.
284. R Halperin, S Zehavi, E Hadas, et al. (2001) Immunohistochemical comparison of primary peritoneal and primary ovarian serous papillary carcinoma. Int J Gynecol Pathol 20 341-345.
285. JP Geisler, HE Geisler, MC Wiemann, et al. (1997) Quantification of p53 in epithelial ovarian cancer. Gynecol Oncol 66 435-438.
286. A Hashi, T Yuminamochi, S Murata, et al. (2003) Wilms tumor gene immunoreactivity in primary serous carcinomas of the fallopian tube, ovary, endometrium, and peritoneum. Int J Gynecol Pathol 22 374-377.
287. M Al Hussaini, A Stockman, H Foster, et al. (2004) WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma. Histopathology 44 109-115.
288. NS Goldstein and A Uzieblo (2002) WT1 immunoreactivity in uterine papillary serous carcinomas is different from ovarian serous carcinomas. Am J Clin Pathol 117 541-545.
289. PJ Zhang, M Shah, GW Spiegel, et al. (2003) Cytokeratin 7 immunoreactivity in rectal adenocarcinomas. Appl Immunohistochem Mol Morphol 11 306-310.
290. JL Rutgers and DA Bell (1992) Immunohistochemical characterization of ovarian borderline tumors of intestinal and mullerian types. Mod Pathol 5 367-371.
291. RW Werling, H Yaziji, CE Bacchi, et al. (2003) CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas. Am J Surg Pathol 27 303-310.
292. CA Moskaluk, H Zhang, SM Powell, et al. (2003) Cdx2 protein expression in normal and malignant human tissues: an immunohistochemical survey using tissue microarrays. Mod Pathol 16 913-919.
293. GM Groisman, A Meir and E Sabo (2004) The value of Cdx2 immunostaining in differentiating primary ovarian carcinomas from colonic carcinomas metastatic to the ovaries. Int J Gynecol Pathol 23 52-57.
294. F Fraggetta, G Pelosi, A Cafici, et al. (2003) CDX2 immunoreactivity in primary and metastatic ovarian mucinous tumours. Virchows Arch 443 782-786.
295. L Tornillo, H Moch, PA Diener, et al. (2004) CDX-2 immunostaining in primary and secondary ovarian carcinomas. J Clin Pathol 57 641-643.
296. BM Ronnett, BM Shmookler, M Diener-West, et al. (1997) Immunohistochemical evidence supporting the appendiceal origin of pseudomyxoma peritonei in women. Int J Gynecol Pathol 16 1-9.
297. JT O'Connell, JS Tomlinson, AA Roberts, et al. (2002) Pseudomyxoma peritonei is a disease of MUC2-expressing goblet cells. Am J Pathol 161 551-564.
298. J Prat, RH Young and RE Scully (1982) Ovarian mucinous tumors with foci of anaplastic carcinoma. Cancer 50 300-304.
299. J Prat and RE Scully (1979) Sarcomas in ovarian mucinous tumors. A report of two cases. Cancer 44 1327-1331.
300. J Prat and RE Scully (1979) Ovarian mucinous tumors with sarcoma-like mural nodules. A report of seven cases. Cancer 44 1332-1344.
301. GE Nichols, SE Mills, TM Ulbright, et al. (1991) Spindle cell mural nodules in cystic ovarian mucinous tumors: A clinicopathologic and immunohistochemical study of five cases. Am J Surg Pathol 15 1055-1062.
302. YF Chan, HC Ho, SM Yau, et al. (1989) Ovarian mucinous tumor with mural nodules of anaplastic carcinoma. Gynecol Oncol 35 112-119.
303. RN Baergen and JL Rutgers (1994) Mural nodules in common epithelial tumors of the ovary. Int J Gynecol Pathol 13 62-71.
304. X Matias-Guiu, I Aranda and J Prat (1991) Immunohistochemical study of sarcoma-like mural nodules in a mucinous cyst-adenocarcinoma of the ovary. Virchows Arch A Pathol Anat Histopathol 419 89-92.
305. S Bague, IM Rodriguez and J Prat (2002) Sarcoma-like mural nodules in mucinous cystic tumors of the ovary revisited – A clinicopathologic analysis of 10 additional cases. Am J Surg Pathol 26 1467-1476.
306. KR Lee and MR Nucci (2003) Ovarian mucinous and mixed epithelial carcinomas of mullerian (endocervical-like) type: A clinicopathologic analysis of four cases of an uncommon variant associated with endometriosis. Int J Gynecol Pathol 22 42-51.
307. J Ordi, DP Schammel, L Rasekh, et al. (1999) Sertoliform endometrioid carcinomas of the ovary: a clinicopathologic and immunohistochemical study of 13 cases. Mod Pathol 12 933-940.
308. EA Dellers, PT Valente, PR Edmonds, et al. (1991) Extrauterine mixed mesodermal tumors: an immunohistochemical study. Arch Pathol Lab Med 115 918-920.
309. PA De Brito, SG Silverberg and JM Orenstein (1993) Carcinosarcoma (malignant mixed müllerian (mesodermal) tumor) of the female genital tract: Immunohistochemical and ultrastructural analysis of 28 cases. Hum Pathol 24 132-142.
310. KL Chang, GS Crabtree, SK Lim-Tan, et al. (1993) Primary extrauterine endometrial stromal neoplasms: a clinicopathologic study of 20 cases and a review of the literature. Int J Gynecol Pathol 12 282-296.
311. R Vang, BP Whitaker, AI Farhood, et al. (2001) Immunohistochemical analysis of clear cell carcinoma of the gynecologic tract. Int J Gynecol Pathol 20 252-259.
312. RI Cameron, P Ashe, DM O'Rourke, et al. (2003) A panel of immunohistochemical stains assists in the distinction between ovarian and renal clear cell carcinoma. Int J Gynecol Pathol 22 272-276.
313. LP Nolan and MK Heatley (2001) The value of immunocytochemistry in distinguishing between clear cell carcinoma of the kidney and ovary. Int J Gynecol Pathol 20 155-159.
314. ES Ho, CR Lai, YT Hsieh, et al. (2001) p53 mutation is infrequent in clear cell carcinoma of the ovary. Gynecol Oncol 80 189-193.
315. M Shimizu, T Nikaido, T Toki, et al. (1999) Clear cell carcinoma has an expression pattern of cell cycle regulatory molecules that is unique among ovarian adenocarcinomas. Cancer 85 669-677.
316. TJ Kwon, JY Ro, C Tornos, et al. (1996) Reduplicated basal lamina in clear-cell carcinoma of the ovary: An immunohistochemical and electron microscopic study. Ultrastruct Pathol 20 529-536.
317. Y Mikami, S Hata, J Melamed, et al. (1999) Basement membrane material in ovarian clear cell carcinoma: correlation with growth pattern and nuclear grade. Int J Gynecol Pathol 18 52-57.
318. J Ordi, C Romagosa, FA Tavassoli, et al. (2003) CD10 expression in epithelial tissues and tumors of the gynecologic tract: a useful marker in the diagnosis of mesonephric, trophoblastic, and clear cell tumors. Am J Surg Pathol 27 178-186.
319. NG Ordonez and B Mackay (2000) Brenner tumor of the ovary: A comparative immunohistochemical and ultrastructural study with transitional cell carcinoma of the bladder. Ultrastruct Pathol 24 157-167.
320. I Riedel, B Czernobilsky, B Lifschitz-Mercer, et al. (2001) Brenner tumors but not transitional cell carcinomas of the ovary show urothelial differentiation: immunohistochemical staining of urothelial markers, including cytokeratins and uroplakins. Virchows Arch Int J Pathol 438 181-191.
321. RA Soslow, RV Rouse, MR Hendrickson, et al. (1996) Transitional cell neoplasms of the ovary and urinary bladder: a comparative immunohistochemical analysis. Int J Gynecol Pathol 15 257-265.
322. O Kaufmann, J Volmerig and M Dietel (2000) Uroplakin III is a highly specific and moderately sensitive immunohistochemical marker for primary and metastatic urothelial carcinomas. Am J Clin Pathol 113 683-687.
323. K Ogawa, SL Johansson and SM Cohen (1999) Immunohistochemical analysis of uroplakins, urothelial specific proteins, in ovarian Brenner tumors, normal tissues, and benign and neoplastic lesions of the female genital tract. Am J Pathol 155 1047-1050.
324. NG Ordonez (2000) Transitional cell carcinomas of the ovary and bladder are immunophenotypically different. Histopathology 36 433-438.
325. I Riedel, B Czernobilsky, B Lifschitz-Mercer, et al. (2001) Brenner tumors but not transitional cell carcinomas of the ovary show urothelial differentiation: immunohistochemical staining of urothelial markers, including cytokeratins and uroplakins. Virchows Arch 438 181-191.
326. NG Ordonez (2003) Application of mesothelin immunostaining in tumor diagnosis. Am J Surg Pathol 27 1418-1428.
327. MA Riopel, EJ Perlman, JD Seidman, et al. (1998) Inhibin and epithelial membrane antigen immunohistochemistry assist in the diagnosis of sex cord-stromal tumors and provide clues to the histogenesis of hypercalcemic small cell carcinomas. Int J Gynecol Pathol 17 46-53.
328. RH Young, E Oliva and RE Scully (1994) Small cell carcinoma of the ovary, hypercalcemic type: A clinicopathological analysis of 150 cases. Am J Surg Pathol 18 1102-1116.
329. P Aguirre, AD Thor and RE Scully (1989) Ovarian small cell carcinoma. Histogenetic considerations based on immunohistochemical and other findings. Am J Clin Pathol 92 140-149.
330. RH Young and RE Scully (1991) Malignant melanoma metastatic to the ovary: A clinicopathologic analysis of 20 cases. Am J Surg Pathol 15 849-860.
331. LP Parker, JL Duong, JT Wharton, et al. (2002) Desmoplastic small round cell tumor: report of a case presenting as a primary ovarian neoplasm. Eur J Gynaecol Oncol 23 199-202.
332. BM Slomovitz, M Girotra, A Aledo, et al. (2000) Desmoplastic small round cell tumor with primary ovarian involvement: case report and review. Gynecol Oncol 79 124-128.
333. RH Young, JH Eichhorn, GR Dickersin, et al. (1992) Ovarian involvement by the intra-abdominal desmoplastic small round cell tumor with divergent differentiation: A report of three cases. Hum Pathol 23 454-464.
334. C Zaloudek, TR Miller and JL Stern (1995) Desmoplastic small cell tumor of the ovary: a unique polyphenotypic tumor with an unfavorable prognosis. Int J Gynecol Pathol 14 260-265.
335. S Kawauchi, T Fukuda, S Miyamoto, et al. (1998) Peripheral primitive neuroectodermal tumor of the ovary confirmed by CD99 immunostaining, karyotypic analysis, and RT-PCR for EWS/FLI-1 chimeric mRNA. Am J Surg Pathol 22 1417-1422.
336. RH Young and RE Scully (1989) Alveolar rhabdomyosarcoma metastatic to the ovary. A report of two cases and a discussion of the differential diagnosis of small cell malignant tumors of the ovary. Cancer 64 899-904.
337. GP Nielsen, E Oliva, RH Young, et al. (1998) Primary ovarian rhabdomyosarcoma: a report of 13 cases. Int J Gynecol Pathol 17 113-119.
338. RJ Paler and JC Felix (1999) Desmin, myoglobin, and muscle-specific actin immunohistochemical staining in a case of embryonal rhabdomyosarcoma of the ovary. Appl Immunohistochem Mol Morphol 7 237-241.
339. Y Katsube, JW Berg and SG Silverberg (1982) Epidemiologic pathology of ovarian tumors: a histopathologic review of primary ovarian neoplasms diagnosed in the Denver Standard Metropolitan Statistical Area, 1 July-31 December 1969 and 1 July-31 December 1979. Int J Gynecol Pathol 1 3-16.
340. PP Koonings, K Campbell, DR Mishell Jr, et al. (1989) Relative frequency of primary ovarian neoplasms: a 10-year review. Obstet Gynecol 74 921-926.
341. AH Stage and WD Grafton (1977) Thecomas and granulosa-theca cell tumors of the ovary: an analysis of 51 tumors. Obstet Gynecol 50 21-27.
342. MT Deavers, A Malpica, NG Ordonez, et al. (2003) Ovarian steroid cell tumors: an immunohistochemical study including a comparison of calretinin with inhibin. Int J Gynecol Pathol 22 162-167.
343. CJR Stewart, MD Jeffers and A Kennedy (1997) Diagnostic value of inhibin immunoreactivity in ovarian gonadal stromal tumours and their histological mimics. Histopathology 31 67-74.
344. AJ Tiltman and Z Haffajee (1999) Sclerosing stromal tumors, thecomas, and fibromas of the ovary: an immunohistochemical profile. Int J Gynecol Pathol 18 254-258.
345. A Chalvardjian and RE Scully (1973) Sclerosing stromal tumors of the ovary. Cancer 31 664-670.
346. S Kawauchi, T Tsuji, T Kaku, et al. (1998) Sclerosing stromal tumor of the ovary. A clinicopathologic, immunohistochemical, ultrastructural, and cytogenetic analysis with special reference to its vasculature. Am J Surg Pathol 22 83-92.
347. M Sabah, M Leader and E Kay (2003) The problem with KIT: clinical implications and practical difficulties with CD117 immunostaining. Appl Immunohistochem Mol Morphol 11 56-61.
348. A Saitoh, Y Tsutsumi, RY Osamura, et al. (1989) Sclerosing stromal tumor of the ovary. Immunohistochemical and electron microscopic demonstration of smooth-muscle differentiation. Arch Pathol Lab Med 113 372-376.
349. JA Shaw, DJ Dabbs and KR Geisinger (1992) Sclerosing stromal tumor of the ovary: An ultrastructural and immunohistochemical analysis with histogenetic considerations. Ultrastruct Pathol 16 363-377.
350. S Ishioka, S Sagae, T Saito, et al. (2000) A case of a sclerosing stromal ovarian tumor that expresses VEGF. J Obstet Gynaecol Res 26 35-38.
351. H Fox (2003) Pathologic prognostic factors in early stage adult-type granulosa cell tumors of the ovary. Int J Gynecol Cancer 13 1-4.
352. ST Schumer and SA Cannistra (2003) Granulosa cell tumor of the ovary. J Clin Oncol 21 1180-1189.
353. JF Hines, MA Khalifa, JL Moore, et al. (1996) Recurrent granulosa cell tumor of the ovary 37 years after initial diagnosis: a case report and review of the literature. Gynecol Oncol 60 484-488.
354. VI Shah, NO Freites, P Maxwell, et al. (2003) Inhibin is more specific than calretinin as an immunohistochemical marker for differentiating sarcomatoid granulosa cell tumour of the ovary from other spindle cell neoplasms. J Clin Pathol 56 221-224.
355. MJ Costa, PB DeRose, LM Roth, et al. (1994) Immunohistochemical phenotype of ovarian granulosa cell tumors: Absence of epithelial membrane antigen has diagnostic value. Hum Pathol 25 60-66.
356. G Gitsch, P Kohlberger, A Steiner, et al. (1992) Expression of cytokeratins in granulosa cell tumors and ovarian carcinomas. Arch Gynecol Obstet 251 193-197.
357. CN Otis, JL Powell, D Barbuto, et al. (1992) Intermediate filamentous proteins in adult granulosa cell tumors: An immunohistochemical study of 25 cases. Am J Surg Pathol 16 962-968.
358. YL Choi, HS Kim and G Ahn (2000) Immunoexpression of inhibin alpha subunit, inhibin/activin betaA subunit and CD99 in ovarian tumors. Arch Pathol Lab Med 124 563-569.
359. MD Gordon, C Corless, AA Renshaw, et al. (1998) CD99, keratin, and vimentin staining of sex cord-stromal tumors, normal ovary, and testis. Mod Pathol 11 769-773.
360. RH Young, GR Dickersin and RE Scully (1984) Juvenile granulosa cell tumor of the ovary. A clinicopathological analysis of 125 cases. Am J Surg Pathol 8 575-596.
361. CJ Zaloudek and HJ Norris (1982) Granulosa tumors of the ovary in children: a clinical and pathologic study of 32 cases. Am J Surg Pathol 6 503-512.
362. D Rakheja and S Sharma (2002) Pathologic quiz case – Cystic and solid ovarian tumor in a 43-year-old woman – Pathologic diagnosis: Cystic juvenile-type granulosa cell tumor of the ovary in an adult. Arch Pathol Lab Med 126 1123-1124.
363. RH Young (1993) Sertoli-Leydig cell tumors of the ovary: review with emphasis on historical aspects and unusual forms. Int J Gynecol Pathol 12 141-147.
364. C Zaloudek and HJ Norris (1984) Sertoli-Leydig tumors of the ovary. A clinicopathologic study of 64 intermediate and poorly differentiated neoplasms. Am J Surg Pathol 8 405-418.
365. RH Young and RE Scully (1984) Well-differentiated ovarian Sertoli-Leydig cell tumors: a clinicopathological analysis of 23 tumors. Int J Gynecol Pathol 3 277-290.
366. RH Young and RE Scully (1985) Ovarian Sertoli-Leydig cell tumors. A clinicopathological analysis of 207 cases. Am J Surg Pathol 9 543-569.
367. RH Young and RE Scully (1983) Ovarian Sertoli-Leydig cell tumors with a retiform pattern – A problem in diagnosis: a report of 25 cases. Am J Surg Pathol 7 755-771.
368. EE Mooney, FF Nogales, C Bergeron, et al. (2002) Retiform Sertoli-Leydig cell tumours: clinical, morphological and immunohistochemical findings. Histopathology 41 110-117.
369. P Aguirre, AD Thor and RE Scully (1989) Ovarian endometrioid carcinomas resembling sex cord-stromal tumors. An immunohistochemical study. Int J Gynecol Pathol 8 364-373.
370. C Guerrieri, B Franlund, H Malmstrom, et al. (1998) Ovarian endometrioid carcinomas simulating sex cord-stromal tumors: a study using inhibin and cytokeratin 7. Int J Gynecol Pathol 17 266-271.
371. QJ Cao, JG Jones and M Li (2001) Expression of calretinin in human ovary, testis, and ovarian sex cord-stromal tumors. Int J Gynecol Pathol 20 346-352.
372. LM Roth, E Liban and B Czernobilsky (1982) Ovarian endometrioid tumors mimicking Sertoli and Sertoli-Leydig cell tumors: Sertoliform variant of endometrioid carcinoma. Cancer 50 1322-1331.
373. RH Young, J Prat and RE Scully (1982) Ovarian endometrioid carcinomas resembling sex cord-stromal tumors. A clinicopathologic analysis of 13 cases. Am J Surg Pathol 6 513-522.
374. RH Young, J Prat and RE Scully (1982) Ovarian Sertoli-Leydig cell tumors with heterologous elements. I. Gastrointestinal epithelium and carcinoid: A clinicopathologic analysis of 36 cases. Cancer 50 2448-2456.
375. P Aguirre, RE Scully and RA DeLellis (1986) Ovarian heterologous Sertoli-Leydig cell tumors with gastrointestinal-type epithelium. An immunohistochemical analysis. Arch Pathol Lab Med 110 528-533.
376. J Prat, RH Young and RE Scully (1982) Ovarian Sertoli-Leydig cell tumors with heterologous elements. II. Cartilage and skeletal muscle. A clinicopathologic analysis of twelve cases. Cancer 50 2465-2475.
377. RH Young and RE Scully (1984) Ovarian Sertoli cell tumors. A report of 10 cases. Int J Gynecol Pathol 2 349-363.
378. JA Ferry, RH Young, G Engel, et al. (1994) Oxyphilic Sertoli cell tumor of the ovary: a report of three cases, two in patients with the Peutz-Jeghers syndrome. Int J Gynecol Pathol 13 259-266.
379. E Benjamin, S Law and LG Bobrow (1987) Intermediate filaments cytokeratin and vimentin in ovarian sex cord-stromal tumours with correlative studies in adult and fetal ovaries. J Pathol 152 253-263.
380. GJR Stewart, CL Nandini and JA Richmond (2000) Value of A103 (melan-A) immunostaining in the differential diagnosis of ovarian sex cord-stromal tumours. J Clin Pathol 53 206-211.
381. JD Seidman, SL Abbondanzo and GL Bratthauer (1995) Lipid cell (steroid cell) tumor of the ovary: immunophenotype with analysis of potential pitfall due to endogenous biotin-like activity. Int J Gynecol Pathol 14 331-338.
382. L Cheng, A Thomas, LM Roth, et al. (2004) OCT4: A novel biomarker for dysgerminoma of the ovary. Am J Surg Pathol 28 1341-1346.
383. TD Jones, TM Ulbright, JN Eble, et al. (2004) OCT4 staining in testicular tumors: a sensitive and specific marker for seminoma and embryonal carcinoma. Am J Surg Pathol 28 935-940.
384. F Kommoss, D Schmidt, W Coerdt, et al. (2001) Immunohistochemical expression analysis of inhibin-alpha and -beta subunits in partial and complete moles, trophoblastic tumors, and endometrial decidua. Int J Gynecol Pathol 20 380-385.
385. WG McCluggage, P Ashe, H McBride, et al. (1998) Localization of the cellular expression of inhibin in trophoblastic tissue. Histopathology 32 252-256.
386. TJ Pelkey, HFJ Frierson, SE Mills, et al. (1999) Detection of the alpha-subunit of inhibin in trophoblastic neoplasia. Hum Pathol 30 26-31.
387. IM Shih and RJ Kurman (1999) Immunohistochemical localization of inhibin-alpha in the placenta and gestational trophoblastic lesions. Int J Gynecol Pathol 18 144-150.
388. E Oliva, E Musulen, J Prat, et al. (1995) Transitional cell carcinoma of the renal pelvis with symptomatic ovarian metastases. Int J Surg Pathol 2 231-236.
389. FF Nogales, IR Avila, A Concha, et al. (1993) Immature endodermal teratoma of the ovary: Embryologic correlations and immunohistochemistry. Hum Pathol 24 364-370.
390. WM Szyfelbein, RH Young and RE Scully (1994) Cystic struma ovarii: A frequently unrecognized tumor: A report of 20 cases. Am J Surg Pathol 18 785-788.
391. WM Szyfelbein, RH Young and RE Scully (1995) Struma ovarii simulating ovarian tumors of other types. A report of 30 cases. Am J Surg Pathol 19 21-29.
392. K Devaney, R Snyder, HJ Norris, et al. (1993) Proliferative and histologically malignant struma ovarii: a clinicopathologic study of 54 cases. Int J Gynecol Pathol 12 333-343.
393. B Sporrong, S Falkmer, SJ Robboy, et al. (1982) Neurohormonal peptides in ovarian carcinoids: an immunohistochemical study of 81 primary carcinoids and of intraovarian metastases from six mid-gut carcinoids. Cancer 49 68-74.
394. J Sidhu and RL Sánchez (1993) Prostatic acid phosphatase in strumal carcinoids of the ovary: An immunohistochemical study. Cancer 72 1673-1678.
395. PA Stagno, RE Petras and WR Hart (1987) Strumal carcinoids of the ovary. An immunohistologic and ultrastructural study. Arch Pathol Lab Med 111 440-446.
396. RR Snyder and FA Tavassoli (1986) Ovarian strumal carcinoid: immunohistochemical, ultrastructural, and clinicopathologic analysis. Int J Gynecol Pathol 5 187-201.
397. K Matsuda, T Maehama and K Kanazawa (2002) Strumal carcinoid tumor of the ovary: a case exhibiting severe constipation associated with PYY. Gynecol Oncol 87 143-145.
398. PM Baker, E Oliva, RH Young, et al. (2001) Ovarian mucinous carcinoids including some with a carcinomatous component – A report of 17 cases. Am J Surg Pathol 25 557-568.
399. J Hussong, FG Crussi and PM Chou (1997) Gonadoblastoma: immunohistochemical localization of Mullerian-inhibiting substance, inhibin, WT-1, and p53. Mod Pathol 10 1101-1105.
400. LM Roth and DE Eglen (1989) Gonadoblastoma. Immunohistochemical and ultrastructural observations. Int J Gynecol Pathol 8 72-81.
401. RG Moore, M Chung, CO Granai, et al. (2004) Incidence of metastasis to the ovaries from nongenital tract primary tumors. Gynecol Oncol 93 87-91.
402. JD Seidman, RJ Kurman and BM Ronnett (2003) Primary and metastatic mucinous adenocarcinomas in the ovaries: incidence in routine practice with a new approach to improve intra-operative diagnosis. Am J Surg Pathol 27 985-993.
403. BM Ronnett, RJ Kurman, BM Shmookler, et al. (1997) The morphologic spectrum of ovarian metastases of appendiceal adenocarcinomas – A clinicopathologic and immunohistochemical analysis of tumors often misinterpreted as primary ovarian tumors or metastatic tumors from other gastrointestinal sites. Am J Surg Pathol 21 1144-1155.
404. SY Park, HS Kim, EK Hong, et al. (2002) Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary. Hum Pathol 33 1078-1085.
405. RH Young and WR Hart (1998) Metastatic intestinal carcinomas simulating primary ovarian clear cell carcinoma and secretory endometrioid carcinoma – A clinicopathologic and immunohistochemical study of five cases. Am J Surg Pathol 22 805-815.
406. Y Gagnon and B Tëtu (1989) Ovarian metastases of breast carcinoma. A clinicopathologic study of 59 cases. Cancer 64 892-898.
407. RH Young, RW Carey and SJ Robboy (1981) Breast carcinoma masquerading as primary ovarian neoplasm. Cancer 48 210-212.
408. C Monteagudo, MJ Merino, N LaPorte, et al. (1991) Value of gross cystic disease fluid protein-15 in distinguishing metastatic breast carcinomas among poorly differentiated neoplasms involving the ovary. Hum Pathol 22 368-372.
409. RW Brown, LB Campagna, JK Dunn, et al. (1997) Immunohistochemical identification of tumor markers in metastatic adenocarcinoma – A diagnostic adjunct in the determination of primary site. Am J Clin Pathol 107 12-19.
410. SK Lau, DJ Luthringer and RN Eisen (2002) Thyroid transcription factor-1: a review. Appl Immunohistochem Mol Morphol 10 97-102.
411. SN Agoff, LW Lamps, AT Philip, et al. (2000) Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors. Mod Pathol 13 238-242.
412. O Kaufmann and M Dietel (2000) Expression of thyroid transcription factor-1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites. Histopathology 36 415-420.
413. NG Ordonez (2000) Value of thyroid transcription factor-1 immunostaining in distinguishing small cell lung carcinomas from other small cell carcinomas. Am J Surg Pathol 24 1217-1223.
414. W Cheuk, MY Kwan, S Suster, et al. (2001) Immunostaining for thyroid transcription factor 1 and cytokeratin 20 aids the distinction of small cell carcinoma from Merkel cell carcinoma, but not pulmonary from extrapulmonary small cell carcinomas. Arch Pathol Lab Med 125 228-231.
415. J Goldblum and WR Hart (1995) Localized and diffuse mesotheliomas of the genital tract and peritoneum in women – A clinicopathologic study of nineteen true mesothelial neoplasms, other than adenomatoid tumors, multicystic mesotheliomas, and localized fibrous tumors. Am J Surg Pathol 19 1124-1137.
416. PB Clement, RH Young and RE Scully (1996) Malignant mesotheliomas presenting as ovarian masses – A report of nine cases, including two primary ovarian mesotheliomas. Am J Surg Pathol 20 1067-1080.
417. SAJ Kerrigan, RT Turnnir, PB Clement, et al. (2002) Diffuse malignant epithelial mesotheliomas of the peritoneum in women – A clinicopathologic study of 25 patients. Cancer 94 378-385.
418. AG Nascimento, GL Keeney and CDM Fletcher (1994) Deciduoid peritoneal mesothelioma: An unusual phenotype affecting young females. Am J Surg Pathol 18 439-445.
419. Z Orosz, P Nagy, Z Szentirmay, et al. (1999) Epithelial mesothelioma with deciduoid features. Virchows Arch 434 263-266.
420. JH Shanks, M Harris, SS Banerjee, et al. (2000) Mesotheliomas with deciduoid morphology – A morphologic spectrum and a variant not confined to young females. Am J Surg Pathol 24 285-294.
421. I Alvarado-Cabrero, RH Young, EC Vamvakas, et al. (1999) Carcinoma of the fallopian tube: a clinicopathological study of 105 cases with observations on staging and prognostic factors. Gynecol Oncol 72 367-379.
422. M Baekelandt, AJ Nesbakken, GB Kristensen, et al. (2000) Carcinoma of the fallopian tube – Clinicopathologic study of 151 patients treated at the Norwegian Radium Hospital. Cancer 89 2076-2084.
423. B Piura and A Rabinovich (2000) Primary carcinoma of the fallopian tube: study of 11 cases. Eur J Obstet Gynecol Reprod Biol 91 169-175.
424. E di Re, G Grosso, F Raspagliesi, et al. (1996) Fallopian tube cancer: incidence and role of lymphatic spread. Gynecol Oncol 62 199-202.
425. LA Youngs and HB Taylor (1967) Adenomatoid tumors of the uterus and fallopian tube. Am J Clin Pathol 48 537-545.
426. TJ Stephenson and PM Mills (1986) Adenomatoid tumours: an immunohistochemical and ultrastructural appraisal of their histogenesis. J Pathol 148 327-335.
427. H Salazar, A Kanbour and F Burgess (1972) Ultrastructure and observations on the histogenesis of mesotheliomas, ‘adenomatoid tumors,’ of the female genital tract. Cancer 29 141-152.
428. KT Mai, HM Yazdi, DG Perkins, et al. (1999) Adenomatoid tumor of the genital tract: evidence of mesenchymal cell origin. Pathol Res Pract 195 605-610.
429. FF Nogales, MA Isaac, D Hardisson, et al. (2002) Adenomatoid tumors of the uterus: an analysis of 60 cases. Int J Gynecol Pathol 21 34-40.
430. EJ Schwartz and TA Longacre (2004) Adenomatoid tumors of the female and male genital tracts express WT1. Int J Gynecol Pathol 23 123-128.
431. B Delahunt, JN Eble, D King, et al. (2000) Immunohistochemical evidence for mesothelial origin of paratesticular adenomatoid tumour. Histopathology 36 109-115.
432. CN Otis (1996) Uterine adenomatoid tumors: immunohistochemical characteristics with emphasis on Ber-EP4 immunoreactivity and distinction from adenocarcinoma. Int J Gynecol Pathol 15 146-151.
433. MH Kariminejad and RE Scully (1973) Female adnexal tumor of probable wolffian origin: a distinctive pathologic entity. Cancer 31 671-677.
434. RH Young and RE Scully (1983) Ovarian tumors of probable wolffian origin: a report of 11 cases. Am J Surg Pathol 7 125-136.
435. FA Tavassoli, R Andrade and M Merino (1990) Retiform wolffian adenoma. CM Fenoglio-Preiser, M Wolffe, F Rilke (Eds) Progress in surgical pathology vol XI New York: Field and Wood Medical Publishers
436. D Daya, RH Young and RE Scully (1992) Endometrioid carcinoma of the fallopian tube resembling an adnexal tumor of probable wolffian origin: a report of six cases. Int J Gynecol Pathol 11 122-130.
437. V Karpuz, SD Berger, K Burkhardt, et al. (1999) A case of endometrioid carcinoma of the fallopian tube mimicking an adnexal tumor of probable wolffian origin. APMIS 107 550-554.
438. M Devouassoux-Shisheboran, SA Silver and FA Tavassoli (1999) Wolffian adnexal tumor, so-called female adnexal tumor of probable wolffian origin (FATWO): immunohistochemical evidence in support of a wolffian origin. Hum Pathol 30 856-863.
439. MA Rahilly, ARW Williams, T Krausz, et al. (1995) Female adnexal tumour of probable wolffian origin: A clinicopathological and immunohistochemical study of three cases. Histopathology 26 69-74.
440. AJ Tiltman and U Allard (2001) Female adnexal tumours of probable wolffian origin: an immunohistochemical study comparing tumours, mesonephric remnants and paramesonephric derivatives. Histopathology 38 237-242.